GOURI Polycaprolactone Injectable Implant - Dermal tissue reconstructive material, synthetic polymer - ARTG 459493
Access comprehensive regulatory information for GOURI Polycaprolactone Injectable Implant - Dermal tissue reconstructive material, synthetic polymer in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 459493 and sponsored by LC & Partners Pty Ltd, manufactured by Dexlevo Inc in South Korea. The device registration started on August 14, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
It is indicated to be used for facial tissue augmentation for mid-to-deep dermal implantation for the correction of moderate to severe facial wrinkles and folds.